New chickenpox shot for kids enters final testing phase
NCT ID NCT07415252
Summary
This study aims to test the safety and immune response of a new chickenpox vaccine called NBP608 in children. About 780 healthy children aged 1 to 12 years will receive either the new vaccine or an already approved chickenpox vaccine. Researchers will compare how well the new vaccine triggers the body's protective defenses against the virus and monitor for any side effects over about 15 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VARICELLA (CHICKENPOX) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.